Abbott integrates CGM into Tandem's automated insulin pump

Description

Abbott (NYSEABT) and Tandem Diabetes Care (Nasdaq:TNDM) announced the integration of FreeStyle Libre 2 CGM into the t:slim X2 insulin pump.

Taking Control Of Your Diabetes® on Instagram: Tandem's t:slim X2 and Abbott's FreeStyle Libre 2 Plus Integration What You Need to Know: 1. Continuous Glucose Monitoring: Real-time glucose readings are now available

Ahmed Sasi on LinkedIn: #esccongress

Manuel Hernández على LinkedIn: Environmental Protection Specialist

Adel Jahed on LinkedIn: #diabetes #instagram #discussion #covidー19

U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems - Mar 6, 2023

Abbott links with Tandem as Medtronic's MiniMed scores new EU nod

Drug Delivery Business News di LinkedIn: Ascensia partners with Snaq on diabetes management

FreeStyle Libre 2 Resources, freestyle libre 2

Manuel Hernández on LinkedIn: CEO, Topaz

Tandem Diabetes Care

Tandem introduces automated insulin delivery system

U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems

Ahmed Sasi on LinkedIn: Abbott integrates CGM into Tandem's automated insulin pump

Shawn Noy on LinkedIn: #abbottproud #floridaatlantic #sharks

Tandem Diabetes Care has positive artificial pancreas data

$ 9.50USD
Score 4.5(150)
In stock
Continue to book